🔗 Permalink

Assignee profile:

ENTERA BIO LTD.

City:

Jerusalem

Country:

Israel

Published Applications:

Last publication date:

2026-05-07

Patent Grants:

Last grant date:

2025-05-27

Top Inventors for applications by ENTERA BIO LTD.

These are the the leading inventors for applications assigned to ENTERA BIO LTD.:

Hillel GALITZER 12 Yad Binyamin, Israel
Gregory BURSHTEIN 12 Modiin, Israel
Phillip M. SCHWARTZ 12 Jerusalem, Israel
Ariel ROTHNER 7 Jerusalem, Israel

Ehud Arbit 6 Englewood, NJ United States
Miriam Kidron 6 Jerusalem, Israel
Constantin ITIN 5 Mevaseret-Zion, Israel
Philip M. SCHWARTZ 1 Jerusalem, Israel

Recent patent applications by ENTERA BIO LTD.

ENTERA BIO LTD. based in Jerusalem, IL has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2026-05-07

US20260124281A1

Human necessities

FORMULATIONS COMPRISING ACID-NEUTRALIZING POLYMER FOR ORAL ADMINISTRATION OF PARATHYROID HORMONE

#2 | 2025-09-11

US20250281396A1

Human necessities

METHODS AND COMPOSITIONS FOR ORAL ADMINISTRATION

#3 | 2025-06-12

US20250186559A1

Human necessities

FORMULATIONS COMPRISING ACID-NEUTRALIZING POLYMER FOR ORAL ADMINISTRATION OF PARATHYROID HORMONE

#4 | 2025-06-12

US20250186558A1

Human necessities

FORMULATIONS COMPRISING ACID-NEUTRALIZING POLYMER FOR ORAL ADMINISTRATION OF ACTIVE AGENTS

#5 | 2025-06-12

US20250186555A1

Human necessities

FORMULATIONS COMPRISING ACID-NEUTRALIZING POLYMER FOR ORAL ADMINISTRATION OF GLUCAGON-LIKE PEPTIDE-2

#6 | 2025-06-12

US20250186554A1

Human necessities

FORMULATIONS COMPRISING ACID-NEUTRALIZING POLYMER FOR ORAL ADMINISTRATION OF GLUCAGON-LIKE PEPTIDE-1 AND ANALOGS THEREOF

#7 | 2024-12-19

US20240415936A1

Human necessities

FORMULATIONS FOR ORAL ADMINISTRATION OF ACTIVE AGENTS

#8 | 2024-12-05

US20240398904A1

Human necessities

FORMULATIONS FOR ORAL ADMINISTRATION OF ACTIVE AGENTS

#9 | 2024-06-06

US20240181020A1

Human necessities

TREATMENT OF HYPOPARATHYROIDISM

#10 | 2022-05-19 ✅ Patent 12,311,051 granted on 2025-05-27

US20220151919A1

Human necessities

Methods and compositions for oral administration

#11 | 2020-05-07 ✅ Patent 12,076,373 granted on 2024-09-03

US20200138913A1

Human necessities

Formulations for oral administration of active agents

#12 | 2019-12-19 ✅ Patent 11,246,827 granted on 2022-02-15

US20190380953A1

Human necessities

Methods and compositions for oral administration

#13 | 2019-07-11 ✅ Patent 12,239,691 granted on 2025-03-04

US20190209657A1

Human necessities

Formulations for oral administration of active agents

#14 | 2018-10-04 ✅ Patent 10,420,721 granted on 2019-09-24

US20180280292A1

Human necessities

Methods and compositions for oral administration

#15 | 2018-02-08

US20180036234A1

Human necessities

TREATMENT OF BONE FRACTURES AND DEFECTS

#16 | 2018-01-25 ✅ Patent 10,583,177 granted on 2020-03-10

US20180021272A1

Human necessities

Formulations for oral administration of active agents

#17 | 2016-03-03 ✅ Patent 10,010,503 granted on 2018-07-03

US20160058699A1

Human necessities

Methods and compositions for oral administration

#18 | 2011-06-16 ✅ Patent 9,186,412 granted on 2015-11-17

US20110142800A1

Human necessities

Methods and compositions for oral administration of insulin

Also check out Entera Bio Ltd.'s (Jerusalem, Israel) applicant profile with 16 patent applications submitted.

AssigneeID:

105710 ⎘